5:23 PM
May 02, 2013
 |  BC Extra  |  Financial News

Ambit sets IPO range

Ambit Biosciences Corp. (San Diego, Calif.) amended its IPO and now plans to sell 4.6 million shares at $13-15. At the $14 mid-point, Ambit would raise $65 million...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >